<DOC>
	<DOC>NCT03061825</DOC>
	<brief_summary>The purpose of this study is to evaluate the clinical performance of the Zenith Alpha™ Abdominal Endovascular Graft for the treatment of abdominal aortic or aorto-iliac aneurysm.</brief_summary>
	<brief_title>Zenith Alpha™ Abdominal Endovascular Graft</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Iliac Aneurysm</mesh_term>
	<criteria>A patient is considered eligible for inclusion in the study if the patient has an infrarenal abdominal aortic or aortoiliac aneurysm and is intended to be treated with the Zenith Alpha™ Abdominal Endovascular Graft Life expectancy less than (&lt;) 2 years Inability or refusal to give informed consent by the patient or legally authorized representative Unwilling or unable to comply with the study followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Aneurysm</keyword>
	<keyword>Aortic Aneurysm</keyword>
	<keyword>Aortic Aneurysm, Abdominal</keyword>
	<keyword>Iliac Aneurysm</keyword>
	<keyword>Vascular Diseases</keyword>
	<keyword>Cardiovascular Diseases</keyword>
	<keyword>Aortic Diseases</keyword>
</DOC>